MTS Health exits Celerion

MTS Health Investors LLC has sold Celerion Holdings Inc to Court Square Capital Partners. Financial terms weren’t announced. Celerion’s management team will continue to own a minority stake. Celerion, of Lincoln, Nebraska, is a clinical research organization that provides clinical trial solutions to pharmaceutical and biotechnology clients conducting early clinical research throughout North America, Europe, and Asia. Lazard Middle Market LLC served as financial adviser, while McDermott Will & Emery LLP acted as legal adviser to Celerion on the transaction.

14 November 2017•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles